Published in TB and Outbreaks Week, October 21st, 1996
The report was presented by researcher J. George and colleagues at the 36th meeting of the American Society for Microbiology's Interscience Conference on Antimicrobial Agents and Chemotherapy, held September 15-18, 1996 in New Orleans, Louisiana.
Streptomycin and other aminoglycosides such as amikacin (AMK) and kanamycin (KAN) are being used more and more frequently in the treatment of multidrug-resistant strains of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week